PTH and secondary hyperparathyroidism: This heightened risk is predominantly attributed to secondary hyperparathyroidism (SHPT), a frequent complication in CKD characterized by disruptions in the calcium–phosphorus metabolism and the elevated secretion of parathyroid hormone (PTH).